Antithrombotic drugs, which include antiplatelet and anticoagulant therapies, prevent and
treat many cardiovascular disorders and, as such, are some of the most commonly …

Given its complexity, the management of atrial fibrillation (AF) has relied increasingly on
expert guideline recommendations; however, discrepancies between these professional …

Abstract Background The PRAGUE-17 (Left Atrial Appendage Closure vs Novel
Anticoagulation Agents in Atrial Fibrillation) trial demonstrated that left atrial appendage …

Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular
atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major …

Introduction Medications cannot exert their effect if not taken as prescribed by patients. Our
objective was to summarise the observational evidence on adherence to oral anticoagulants …

Abstract Purpose Oral anticoagugulants (OACs) effectively reduce the risk for ischemic
stroke in patients with atrial fibrillation (AF), but undertreatment and poor persistence with …

In this article we compare and contrast the current recommendations, and highlight the
important differences, in the American College of Cardiology/American Heart …

In patients with non-valvular atrial fibrillation, oral anticoagulation with vitamin K antagonists
reduces the risk of stroke by more than 60%. But vitamin K antagonists have limitations …

Abstract Background: CMS Star Ratings help inform beneficiaries about the performance of
health and drug plans. Medication adherence is currently weighted at nearly half of a Part D …

Introduction Uncomplicated pediatric umbilical hernias are common and most close
spontaneously. No formal practice guidelines exist regarding the optimal timing and …